Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07531472Not yet recruiting
Trial of hyaluronic acid sodium composite gel for injection in epistaxis (2 arms), sponsored by Assiut University. Primary endpoint: Recurrence rate of epistaxis at 14 days. Planned start May 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07531472.